Clinical Computing PLC
07 June 2006
Clinical Computing Plc
Issue of Shares
Clinical Computing Plc (the 'Company'), the international developer of clinical
information systems for the healthcare market, is pleased to announce an equity
fundraising of £102,375 by placing 1,575,000 new ordinary 5p shares in the
Company at 6.5 pence per share representing 4.99% of the ordinary shares in
issue. The issue of equity is within the Company's existing authorities to
issue up to 5 per cent of its existing issued share capital on a non pre-emptive
basis granted at the AGM held on 8 June 2005.
It is expected that the new ordinary shares will be admitted to listing on the
Official List of the UK Listing Authority and to trading on the main market of
the London Stock Exchange on 12 June 2006.
The shares in issue following this notification are 33,110,361.
Enquiries:
Clinical Computing plc Tel: 020 8747 8744
Joseph Marlovits, Company Secretary joe.marlovits@ccl.com
Parkgreen Communications Ltd Tel: 020 7786 9600
Paul McManus Mob: 07980 541 893
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.